logo
logo

CURE Pharmaceutical Closes $10 Million Financing

Nov 02, 2020•almost 5 years ago

Amount Raised

$10 Million

Oxnard

Description

CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the “Notes”). Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.

Company Information

Company

Cure Pharmaceutical Holding Corp.

Location

Oxnard, California, United States

About

CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech